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Abstract
Excessive growth of long bones in patients with homocystinuria is still unexplained and previous work incriminating
homocysteic acid could not be confirmed by others. In vitro studies from our laboratory showed that homocysteine
stimulated growth in a clonogenic assay. This observation made us study plasma cyclin dependent kinase (CDK),
homocyst(e)ine and homocysteic acid in 10 patients with homocystinuria and 20 controls. In addition, homocysteine and
homocysteic acid were tested in a clonogenic assay to correlate the growth promoting activity with CDK. Plasma CDK
(protein) correlated strongly with homocysteine (r = 0.84) but not with homocysteic acid. Supernatants of the clonogenic
assay samples showed up to three times higher CDK levels in the presence of homocyst(e)ine but not homocysteic acid. In
vitro data and the strong correlation between homocysteine and CDK suggest a role for homocysteine stimulating CDK, the
starter of mitosis, with subsequent stimulation of growth. z 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Bone abnormalities are a cardinal symptom of ho-
mocystinurias. The skeletal disproportion is due to
excessive growth of the long bones [1], although the
upper/lower segment ratio of homocystinuric patients
may be exaggerated by scoliosis [2]. Clopath and
coworkers reported that homocysteic acid (HCA)
promoted growth of hypophysectomized rats as as-
sayed by observation of increased thickness of the
epiphyseal cartilage of the tibia and by observation
of tail growth. They related their ¢ndings to acceler-
ated growth in homocystinuria, initiation of arterio-
sclerosis and control of cellular growth [3]. Chrza-
nowska and coworkers attempted to repeat these
experiments using a larger number of hypophysec-
tomized animals studying the e¡ects of homocysteic
acid on tibial epiphyseal cartilage thickness, serum
somatomedin activity and liver DNA polymerase:
no growth promoting activity was found [4].
Tsai and coworkers [5] reported growth promotion
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of vascular smooth muscle cells by homocysteine
(HC), we reported increased growth by homocysteine
thiolactone in a clonogenic assay [6], collagen accu-
mulation in aortic tissue in vivo [7] and increased
cyclin dependent kinase (CDK) in aortic tissue of
rats fed homocysteine but not homocysteic acid [8].
Based upon these observations we decided to study
CDK in plasma of patients with hyperhomocyst(e)i-
nemic states and the e¡ect of HC and HCA on CDK
in vitro. We could not ¢nd any growth promoting
e¡ect of homocysteic acid in vitro in a clonogenic
assay but detected growth promotion by homocys-
teine in vitro and in vivo by the correlation with
CDK, a key enzyme involved in the starting of mi-
tosis [9].
2. Patients, materials and methods
2.1. Patients
Plasma of 10 patients with hyperhomocysteinemia
was obtained from patients treated at the University
Hospital Nijmegen. Nine of them had cystathionine
L-synthase de¢ciency and one had the thermolabile
form of methylenetetrahydrofolate reductase de¢-
ciency [10].
Cystathionine L-synthase de¢ciency was estab-
lished by severely elevated levels of homocysteine
and methionine and decreased (6 5% of normals)
enzyme activity in ¢broblasts. These patients were
examined for plasma homocyst(e)ine, homocysteic
acid and CDK levels. EDTA blood was drawn, put
on ice and centrifuged 10 min at 3000Ug within 1 h.
The characterization of patients and clinical data are
given in Table 1. Twenty healthy persons (9 females,
11 males; mean age 34 years, S.D. 12 years) were
recruited and served as controls.
Plasma samples of patients and controls were
stored at 380‡C for a period of at most 3 months,
identical sample handling procedures were performed
and samples were analyzed accordingly.
2.2. Determination of plasma and cell culture
supernatant cyclin dependent p34cdc2 kinase
(CDK)
The detection of p34cdc2 kinase (CDK) was
achieved by an enzyme linked immunosorbent assay
(ELISA) using the commercially available kit In vivo
CDK ELISA ([8]; Paracelsian Biotechnology for
Toxicological Testing and Research, Ithaca, NY).
The principle of the assay is that proliferative stim-
ulation is determined through the detection of CDK.
In the G0 stage of the cell cycle expression of CDK is
minimal but as cells are stimulated into G1 the ex-
pression of CDK increases.
The standards cd RLHCl Positive CDK Control
Table 1
Clinical characterization of patients
Patient Age Sex Heightb (cm) Weightb (kg) Treatment
at diagnosisa at study Marfanoidc Vit. B6 Folate Vit. B12 Betaine
1B53 25 31 m 188 80 3 +
2M61 23 33 m 190 89 + + +
3B61 26 33 m 191 77 + + + +
4B58 27 36 m 191 87 + + + + +
5S25 61 65 f 165e 56 +
6V43d 50 50 m 170 64 + +
7D67 3 27 m 187 77 + + +
8D65 4 28 m 164 84 + + +
9U78 7 16 f 171 64 + + +
10G62 31 31 f 180 63 +
aTreatment started since diagnosis except in patient 6.
bHeight/weight at study.
cMarfanold because of dolichostenomelia, arachnodactyly or thorax deformation.
d5-Methylenetetrahydrofolate reductase de¢ciency because of thermolability.
eHeight in the presence of kyphoscoliosis.
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and cd RLLCl Negative CDK Control were used for
calibration. The supplier’s instructions were fol-
lowed.
CDK values are expressed in fM/l (plasma or cell
culture supernatant).
2.3. Determination of homocyst(e)ine and
homocysteic acid
The principle of Fermo and coworkers describing
the concomitant determination of total homocysteine
(tHcy) and homocysteic acid (HCA [11]) was applied
with minor modi¢cations [12].
200 Wl of plasma was added to 300 Wl distilled
water (HPLC grade, Merck), 300 Wl of 9 M urea
pH 9.0, 30 Wl amyl alcohol, 45 Wl sodium tetrabo-
rate/DMSO solution (3 M NaBH4 in 0.4 N
NaOH:DMSO 2:1). This mixture was incubate 30
min at 50‡C, then 500 Wl of 6% perchloric acid was
added, the solution was mixed and spun down. 500
Wl of the supernatant were added to 100 Wl iodoacetic
acid (9.3 mg iodoacetic acid in 0.1 M borate bu¡er
pH 9.5) and 100 Wl of 3 M NaOH. 100 Wl of this
solution was reacted with 100 Wl OPA solution
(Pierce 26025) and 50 Wl was injected after a reaction
time of 60 s.
A Waters system controller 600E, a Waters sample
715 processor, a Waters 470 £uorescence detector
and the Masima 825 Data processing system were
used.
The solvents used for elution were solvent A:
water:propionate bu¡er:acetonitrile (60:30:10); pro-
pionate bu¡er consisted of 15.68 ml propionic
acid+49.6 g Na2HPO4 anhydride in distilled water,
adjusted to pH 6.5. Solvent B was water:acetoni-
trile:methanol (45:30:25). The gradient was as given
previously [12]. Detection was at 230 nm excitation
and 417 nm emission. The column was a Beckman
Ultrasphere ODS C18, 250U4.6 mm.
As revealed by previous experiments we could rule
out that the reductive step used in this method does
not a¡ect HCA levels; furthermore, no e¡ect of
HCA on tHcy or vice versa was observed. The stabil-
ity of HCA was preserved at room temperature for
3 days and was unchanged for a period of 3 months
at the storage temperature of 380‡C (data not
shown). The CV of the method listed above was
3.9% for tHcy and 4.1% for HCA; recovery was
96.2%. Samples from cases and controls were ana-
lyzed on the same day in the same run.
2.4. The clonogenic assay
The HT 29 human colonic carcinoma cell line was
purchased from ATCC (American Type Culture Col-
lection, Rockville, MD, USA).
The HT 29 human colonic carcinoma cell line was
grown in RPMI 1640 medium supplemented with
10% heat inactivated FBS (Gibco, Grand Island,
NY, USA), penicillin (100 U/ml) and streptomycin
(100 U/ml). The cells were incubated at 37‡C in a
humidi¢ed atmosphere of 5% CO2/95% air.
For subculture, monolayer cells were dispersed
with 0.25% trypsin plus 1 mM EDTA at 37‡C for
30 min. After centrifugation the cells were resus-
pended in fresh medium.
For the clonogenic assay exponentially growing
cells were seeded in 24 well plates in medium con-
taining 10% FBS at a density of 150 cells per well.
Six hours after seeding various concentrations of the
test compounds homocysteine thiolactone (HCTL)
and homocysteic acid (HCA) were added at 0^125
Wg/ml (see Fig. 1). The cells were then maintained
in the medium for 10 days. Triplicate samples were
used for each compound concentration. Colonies
consisting of more than 50 cells were counted [13].
1U106 HT 29 cells in culture £asks were incubated
under identical conditions with homocysteine or ho-
mocysteic acid in the concentration shown in Fig. 1
and CDK was determined in the supernatants.
Fig. 1. Presentation of tHcy, HCA and CDK in patients with
hyperhomocyst(e)inemia and controls.
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2.5. Statistical calculations
The Mann-Whitney U test was applied for the
comparison of groups and the Spearman rank corre-
lation was performed for the determination of the
correlation coe⁄cient (SAS). Signi¢cance was con-
sidered at the P6 0.05 level.
3. Results
Plasma tHcy and HCA results are given in Fig. 1.
Plasma tHcy ad HCA were signi¢cantly higher in the
group of patients with homocystinuria (Fig. 1). tHcy
and HCA levels did not shown any signi¢cant corre-
lation.
Plasma CDK levels are presented in Fig. 2. They
were signi¢cantly elevated in patients with homocys-
tinuria. In the patients group tHcy (r = 0.95, Spear-
man rank correlation) but not HCA levels correlated
signi¢cantly with plasma CDK levels.
CDK signi¢cantly parallelled cell culture superna-
tant HCTL levels (r = 0.98; Fig. 2). HCA did not
increase CDK levels in the supernatants (data not
shown).
4. Discussion
Plasma tHcy and HCA levels of patients with hy-
perhomocysteinemia were signi¢cantly higher than in
the control panel. HCA levels did not, however, cor-
relate with tHcy.
Even the highest plasma Hcy level of 252 Wmol/l
was not accompanied by a corresponding rise in
HCA levels. This does not rule out the possibility
that HCA could be responsible for excess growth
in homocystinuria. The lack of correlation between
tHcy and HCA, however surprising, could be ex-
plained by di¡erences in the HC oxidizing enzyme
systems as well as by non-enzymatic reactions: the
oxidant status, reported to be changed in homocys-
tinuria [14], as well as medication (betaine, vitamins
B6, B12, folate) may interfere with HCA handling or
formation. The fact that no correlation of HCA with
CDK was found makes the hypothesis that HCA
induces excess growth rather improbable. The strong
correlation of tHcy with CDK suggests a role of HC
in excessive growth.
In 1988 Draetta and coworkers reported on the
synthesis and distribution of a 34 kDa protein in
rat tissues and cell lines. They found that increased
synthesis of p34 was due to an increase in abundance
of translatable p34 mRNA. Their data were consis-
tent with the possibility that p34 played a role in cell
division in higher vertebrates [15]. Labbe and co-
workers reported in the same year that in star¢sh
and amphibian oocytes the activity of a major pro-
tein kinase (CDK) increased dramatically at meiotic
and mitotic nuclear divisions [16]. Riabowol and
coworkers showed one year later that cdc2 CDK
was a component of M phase promoting factor in
Xenopus oocytes and that the homologous kinase in
human HeLa cells was maximally active during mi-
tosis [17]. McGowan and coworkers have shown that
the activity of that kinase was regulated in a cell
cycle dependent manner by reversible phosphoryla-
tion and through association with other proteins [18].
A further characterization of cyclin dependent kin-
ases in the human system was given in a recent paper
by Lucas and coworkers [19]. Further elucidation of
the system was provided by Dutta and Stillman
showing that cdc2 family kinases phosphorylate a
human cell DNA replicating factor, RPA, and acti-
vate DNA replication [20].
We used that enzyme to test the hypothesis that
HC itself and not HCA ^ as suggested in the liter-
ature ^ could be responsible for excess growth. To
strengthen this hypothesis we tested HCTL and
HCA for their growth promoting activity in a clono-
genic assay. Homocysteine as HCTL clearly in-
Fig. 2. CDK levels parallelled HCTL concentrations in a clono-
genic assay.
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creased proliferation in contrast to its oxidized form,
HCA [6].
A publication in 1956 showed that thiols do play a
role in growth promotion: Stern reported in Science
that thiol groups are important for cell division and
referred to the observation that the nitroprusside re-
action in proliferating tissues was high in proliferat-
ing tissues and that ‘thiol poisons’ i.e. thiol group
blocking agents, inhibit cell division, which was re-
versible by the addition of glutathione or related thi-
ols. He also clearly described the coincidental in-
crease of thiols with mitosis in the lily Lilium
longi£orum [21]. Further related information on thi-
ols and cell division was published by Mazia [22].
Our observation that plasma tHcy correlates with
a cyclin dependent kinase suggests that HC and not
HCA mediates growth in patients with homocystinu-
ria and that this e¡ect could be mediated via cyclin
dependent kinases. In a previous paper we have
shown that HC increased CDK protein and mRNA
steady-state levels [8] but we cannot exclude that ho-
mocysteine may work by activating protooncogenes
which in turn subsequently would activate CDK. The
interaction between protooncogenes and cdk is well-
documented and this system in turn could be in-
volved in growth promotion [23^25].
The innovative ¢nding of this report is the associ-
ation of HC with a growth related kinase which
could serve as a possible explanation and a hypoth-
esis together with the ¢ndings in the clonogenic assay
for excess growth and proliferation in hyperhomo-
cysteinemic states.
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